31 C newsmobile
Elections 2026Sports / newsmobile
Novo Nordisk Launches India
Danish pharmaceutical company Novo Nordisk has launched Awiqli (insulin icodec) in India, the worlds first once-weekly basal insulin for adults with Type 1 and Type 2 diabetes. India becomes the sixth country to introduce the therapy, which reduces insulin injections from 365 to just 52 a year. Delivered through the FlexTouch pen device, Awiqli is []
9 Jul 2026 4:27 pm